HomeCompareLGNRF vs MRK

LGNRF vs MRK: Dividend Comparison 2026

LGNRF yields 176.99% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LGNRF wins by $11.8K in total portfolio value
10 years
LGNRF
LGNRF
● Live price
176.99%
Share price
$1.13
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$68.6K
Annual income
$60.20
Full LGNRF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — LGNRF vs MRK

📍 LGNRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLGNRFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LGNRF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LGNRF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LGNRF
Annual income on $10K today (after 15% tax)
$15,044.25/yr
After 10yr DRIP, annual income (after tax)
$51.17/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,277.24/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LGNRF + MRK for your $10,000?

LGNRF: 50%MRK: 50%
100% MRK50/50100% LGNRF
Portfolio after 10yr
$62.7K
Annual income
$4,929.17/yr
Blended yield
7.86%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LGNRF
No analyst data
Altman Z
1.0
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LGNRF buys
0
MRK buys
0
No recent congressional trades found for LGNRF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLGNRFMRK
Forward yield176.99%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$68.6K$56.8K
Annual income after 10y$60.20$9,798.13
Total dividends collected$29.5K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LGNRF vs MRK ($10,000, DRIP)

YearLGNRF PortfolioLGNRF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$19,550$8,849.56$11,206$366.19+$8.3KLGNRF
2$29,002$8,084.34$12,650$502.35+$16.4KLGNRF
3$36,637$5,604.38$14,407$694.19+$22.2KLGNRF
4$42,510$3,308.26$16,585$967.82+$25.9KLGNRF
5$47,279$1,793.72$19,342$1,363.89+$27.9KLGNRF
6$51,521$932.23$22,913$1,947.19+$28.6KLGNRF
7$55,602$474.70$27,662$2,823.89+$27.9KLGNRF
8$59,734$239.40$34,159$4,173.35+$25.6KLGNRF
9$64,035$120.18$43,337$6,308.80+$20.7KLGNRF
10$68,578$60.20$56,776$9,798.13+$11.8KLGNRF

LGNRF vs MRK: Complete Analysis 2026

LGNRFStock

Legend Holdings Corporation, together with its subsidiaries, operates in the industrial operations, and industrial incubations and investments business in the People's Republic of China and internationally. The Industrial Operations segment provides devices and infrastructure, as well as creates solutions, services, and software; researches, develops, produces, and sells advanced material products; engages in agriculture and food related business; and offers integrated banking services, including corporate and institutional banking, retail banking, private banking, capital markets, etc. The Industrial Incubations and Investments segment invests in private equity and venture capital funds as a limited partner; holds interest in the general partners of various funds; and makes angel investments in technology start-ups, as well as minority investments in other entities. This segment also engages in aviation logistics, financial services, medical and health care, and office leasing services related businesses. The company also develops car management software, as well as provides car services information consultant services; develops and produces chemicals and energy materials; provides information and medical consultation services; and engages in real estate investment and asset management, enterprise management, and project investment businesses. In addition, it engages in agriculture products planting and trading, and food investment activities; trades, processes, and sells seafood and other animal protein-related products; and produces and sells salmon. Legend Holdings Corporation was incorporated in 1984 and is headquartered in Beijing, the People's Republic of China.

Full LGNRF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this LGNRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LGNRF vs SCHDLGNRF vs JEPILGNRF vs OLGNRF vs KOLGNRF vs MAINLGNRF vs JNJLGNRF vs ABBVLGNRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.